This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Ucl Business Plc, Other. Active years: 2018-2023.
Company Filing History:
3 out of 299 
1 out of 834,411 Years Active: 2018-2023
Title: Fausto Andreola: Innovator in Liver Disease Treatment
Introduction
Fausto Andreola is a notable inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the treatment of liver diseases. With a total of 4 patents to his name, Andreola's work focuses on innovative therapies that target critical biomarkers and mechanisms involved in liver failure.
Latest Patents
Andreola's latest patents include groundbreaking inventions related to the treatment of necroptosis. His research reveals that necroptosis serves as a novel biomarker and therapeutic target for patients suffering from liver failure, including acute liver failure (ALF) and acute-on-chronic liver failure (ACLF). By detecting and quantifying RIPK1, MLKL, or RIPK3 in serum or plasma, these biomarkers can predict outcomes in ACLF and other diseases characterized by aberrant necroptosis. His invention proposes that antagonizing these proteins may alleviate many of the adverse effects associated with ACLF. Furthermore, he has developed methods for treating diseases linked to hepatic stellate cell activation, such as non-alcoholic fatty liver disease (NAFLD), fibrosis, and liver cancer, through ammonia-lowering therapies.
Career Highlights
Throughout his career, Andreola has worked with various organizations, including UCL Business Plc. His innovative approaches and research have positioned him as a key figure in the medical community, particularly in the realm of liver disease treatment.
Collaborations
Andreola has collaborated with esteemed colleagues, including Rajiv Jalan and Rajeshwar Prosad Mookerjee. These partnerships have further enhanced his research and contributed to the advancement of therapeutic strategies in liver health.
Conclusion
Fausto Andreola's contributions to medical research, particularly in liver disease treatment, highlight his role as an influential inventor. His innovative patents and collaborative efforts continue to pave the way for new therapeutic approaches in the medical field.